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Abstract
Automatic Chemical Design is a framework for generating novel molecules with
optimized properties. The original scheme, featuring Bayesian optimization over
the latent space of a variational autoencoder, suffers from the pathology that it
tends to produce invalid molecular structures. First, we demonstrate empirically
that this pathology arises when the Bayesian optimization scheme queries latent
points far away from the data on which the variational autoencoder has been
trained. Secondly, by reformulating the search procedure as a constrained Bayesian
optimization problem, we show that the effects of this pathology can be mitigated,
yielding marked improvements in the validity of the generated molecules. We posit
that constrained Bayesian optimization is a good approach for solving this class of
training set mismatch in many generative tasks involving Bayesian optimization
over the latent space of a variational autoencoder.
1 Introduction
There are two fundamental ways in which machine learning can be leveraged in chemical design:
1. To evaluate a molecule for a given application.
2. To find a promising molecule for a given application.
There has been much progress in the first use-case through the development of quantitative structure
activity relationship (QSAR) models using deep learning [Ma et al., 2015]. These models have
achieved state-of-the-art results in predicting properties Ryu et al. [2018a,b], Turcani et al. [2018],
Dey et al. [2018], Coley et al. [2017], Gu et al. [2019], Zeng et al. [2018], Coley et al. [2019a] as
well as property uncertainties Cortés-Ciriano and Bender [2018], Zhang and Lee [2019], Janet et al.
[2019], Ryu et al. [2019] of known molecules.
The second use-case, finding new molecules that are useful for a given application, is arguably more
important however. One existing approach for finding molecules that maximize an application-specific
metric involves searching a large library of compounds, either physically or virtually Pyzer-Knapp
et al. [2015], Playe [2019]. This has the disadvantage that the search is not open-ended; if the
molecule is not in the library you specify, the search won’t find it.
A second method involves the use of genetic algorithms. In this approach, a known molecule acts as
a seed and a local search is performed over a discrete space of molecules. Although these methods
have enjoyed success in producing biologically active compounds, an approach featuring a search
over an open-ended, continuous space would be beneficial. The use of geometrical cues such as
gradients to guide the search in continuous space could accelerate both drug [Pyzer-Knapp et al.,
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Figure 1: The SMILES representation and one-hot encoding for benzene. For purposes of illustration,
only the characters present in benzene are shown in the one-hot encoding. In practice there is a
column for each character in the SMILES alphabet.
2015, Gómez-Bombarelli et al., 2016] and materials [Hachmann et al., 2011, 2014] discovery by
functioning as a high-throughput virtual screen of unpromising candidates.
Recently, Gómez-Bombarelli et al. [Gómez-Bombarelli et al., 2018] presented Automatic Chemical
Design, a variational autoencoder (VAE) architecture capable of encoding continuous representations
of molecules. In continuous latent space, gradient-based optimization is leveraged to find molecules
that maximize a design metric.
Although a strong proof of concept, Automatic Chemical Design possesses a deficiency in so far as it
fails to generate a high proportion of valid molecular structures. The authors hypothesize Gómez-
Bombarelli et al. [2018] that molecules selected by Bayesian optimization lie in “dead regions” of
the latent space far away from any data that the VAE has seen in training, yielding invalid structures
when decoded.
The principle contribution of this paper is to present an approach based on constrained Bayesian
optimization that generates a high proportion of valid sequences, thus solving the training set
mismatch problem for VAE-based Bayesian optimization schemes.
2 Methods
2.1 SMILES Representation
SMILES strings Weininger [1988] are a means of representing molecules as a character sequence.
This text-based format facilitates the use of tools from natural language processing for applications
such as chemical reaction prediction Schwaller et al. [2018a], Jin et al. [2017], Coley et al. [2019b],
Schwaller et al. [2018b], Bradshaw et al. [2019a,b]. To make the SMILES representation compatible
with the VAE architecture, the SMILES strings are in turn converted to one-hot vectors indicating the
presence or absence of a particular character within a sequence as illustrated in Figure 1.
2.2 Variational Autoencoders
Variational autoencoders Kingma and Welling [2014], Kingma et al. [2014] provide a means of
mapping moleculesm to and from continuous values z in a latent space. The encoding z is interpreted
as a latent variable in a probabilistic generative model over which there is a prior distribution p(z).
The probabilistic decoder is defined by the likelihood function pθ(m|z). The posterior distribution
pθ(z|m) is interpreted as the probabilistic encoder. The parameters of the likelihood pθ(m|z) as well
as the parameters of the approximate posterior distribution qφ(z|m) are learned by maximizing the
evidence lower bound (ELBO)
L(φ, θ;m) = Eqφ(z|m)[log pθ(m, z)− log qφ(z|m)].
Variational autoencoders have been coupled with recurrent neural networks by Bowman et al. [2015]
to encode sentences into a continuous latent space. This approach is followed for the SMILES format
both by Gómez-Bombarelli et al. [2018] and here. The SMILES variational autoencoder, together
with our constraint function, is shown in Figure 2.
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Figure 2: The SMILES Variational Autoencoder with the learned constraint function illustrated by a
circular feasible region in the latent space.
2.3 Objective Functions for Bayesian Optimization of Molecules
Bayesian optimization is performed in the latent space of the variational autoencoder in order to find
molecules that score highly under a specified objective function. We assess molecular quality on the
following objectives:
J logPcomp(z) = logP(z)− SA(z)− ring-penalty(z),
JQEDcomp(z) = QED(z)− SA(z)− ring-penalty(z),
JQED(z) = QED(z).
z denotes a molecule’s latent representation, logP(z) is the water-octanol partition coefficient, QED(z)
is the quantitative estimate of drug-likeness Bickerton et al. [2012] and SA(z) is the synthetic
accessibility Ertl and Schuffenhauer [2009]. The ring penalty term is as featured in Gómez-Bombarelli
et al. [2018]. The “comp” subscript is designed to indicate that the objective function is a composite
of standalone metrics.
It is important to note, that the first objective, a common metric of comparison in this area, is
mis-specified as had been pointed out by Griffiths et al. [2018]. From a chemical standpoint it is
undesirable to maximize the logP score as is being done here. Rather it is preferable to optimize logP
to be in a range that is in accordance with the Lipinski Rule of Five Lipinski et al. [1997]. We use the
penalized logP objective here because regardless of its relevance for chemistry, it serves as a point of
comparison against other methods.
2.4 Constrained Bayesian Optimization of Molecules
We now describe our extension to the Bayesian optimization procedure followed by Gómez-
Bombarelli et al. [2018]. Expressed formally, the constrained optimization problem is
max
z
f(z) s.t. Pr(C(z)) ≥ 1− δ
where f(z) is a black-box objective function, Pr(C(z)) denotes the probability that a Boolean
constraint C(z) is satisfied and 1− δ is some user-specified minimum confidence that the constraint
is satisfied Gelbart et al. [2014]. The constraint is that a latent point must decode successfully a
large fraction of the times decoding is attempted. The specific fractions used are provided in the
results section. The black-box objective function is noisy because a single latent point may decode to
multiple molecules when the model makes a mistake, obtaining different values under the objective.
In practice, f(z) is one of the objectives listed in section 2.3.
2.5 Expected Improvement with Constraints (EIC)
EIC may be thought of as expected improvement (EI),
EI(z) = Ef(z)
[
max(0, f(z)− η)],
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that offers improvement only when a set of constraints are satisfied [Schonlau et al., 1998]:
EIC(z) = EI(z) Pr(C(z)).
The incumbent solution η in EI(z), may be set in an analogous way to vanilla expected improvement
Gelbart [2015] as either:
1. The best observation in which all constraints are observed to be satisfied.
2. The minimum of the posterior mean such that all constraints are satisfied.
The latter approach is adopted for the experiments performed in this paper. If at the stage in the
Bayesian optimization procedure where a feasible point has yet to be located, the form of acquisition
function used is that defined by [Gelbart, 2015]
EIC(z) =
{
Pr(C(z)EI(z), if ∃z, Pr(C(z)) ≥ 1− δ
Pr(C(z)), otherwise
with the intuition being that if the probabilistic constraint is violated everywhere, the acquisition
function selects the point having the highest probability of lying within the feasible region. The
algorithm ignores the objective until it has located the feasible region.
3 Related Work
The literature concerning generative models of molecules has exploded since the first work on the
topic Gómez-Bombarelli et al. [2018]. Current methods feature molecular representations such as
SMILES [Janz et al., 2018, Segler et al., 2017, Blaschke et al., 2017, Skalic et al., 2019, Ertl et al.,
2017, Lim et al., 2018, Kang and Cho, 2018, Sattarov et al., 2019, Gupta et al., 2018, Harel and
Radinsky, 2018, Yoshikawa et al., 2018, Bjerrum and Sattarov, 2018, Mohammadi et al., 2019]
and graphs [Simonovsky and Komodakis, 2018, Li et al., 2018a, Jin et al., 2018, De Cao and Kipf,
2018, Kusner et al., 2017, Dai et al., 2018, Samanta et al., 2019, Li et al., 2018b, Kajino, 2019, Jin
et al., 2019, Bresson and Laurent, 2019, Lim et al., 2019, Pölsterl and Wachinger, 2019, Krenn et al.,
2019, Maziarka et al., 2019, Madhawa et al., 2019, Shen, 2018, Korovina et al., 2019] and employ
reinforcement learning Guimaraes et al. [2017], Zhou et al. [2019], Putin et al. [2018a], You et al.
[2018], Putin et al. [2018b], Yang et al. [2017], Wei et al. [2019], Ståhl et al. [2019], Kraev [2018],
Olivecrona et al. [2017], Popova et al. [2019] as well as generative adversarial networks Prykhodko
et al. [2019] for the generative process. These methods are well-summarized by a number of recent
review articles [Xue et al., 2019, Elton et al., 2019, Schwalbe-Koda and Gómez-Bombarelli, 2019,
Chang, 2019, Sanchez-Lengeling and Aspuru-Guzik, 2018a]. In this work we focus solely on VAE-
based Bayesian optimization schemes for molecule generation and so we do not benchmark model
performance against the aforementioned methods. Principally, we are concerned with highlighting
the issue of training set mismatch in VAE-based Bayesian optimizations schemes and demonstrating
the superior performance of a constrained Bayesian optimization approach.
4 Results and discussion
4.1 Experiment I: Drug Design
In this section we conduct an empirical test of the hypothesis from [Gómez-Bombarelli et al.,
2018] that the decoder’s lack of efficiency is due to data point collection in “dead regions” of
the latent space far from the data on which the VAE was trained. We use this information to
construct a binary classification Bayesian Neural Network (BNN) to serve as a constraint func-
tion that outputs the probability of a latent point being valid, the details of which will be dis-
cussed in the section on labelling criteria. Secondly, we compare the performance of our con-
strained Bayesian optimization implementation against the original model (baseline) in terms of
the numbers of valid and drug-like molecules generated. Thirdly, we compare the quality of the
molecules produced by constrained Bayesian optimization with those of the baseline model. The
code for all experiments has been made publicly available at https://github.com/Ryan-Rhys/
Constrained-Bayesian-Optimisation-for-Automatic-Chemical-Design
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(a) % Valid Molecules (b) % Methane Molecules (c) % Drug-like Molecules
Figure 3: Experiments on 5 disjoint sets comprising 50 latent points each. Very small (VS) Noise are
training data latent points with approximately 1% noise added to their values, Small (S) Noise have
10% noise added to their values and Big (B) Noise have 50% noise added to their values. All latent
points underwent 500 decode attempts and the results are averaged over the 50 points in each set.
The percentage of decodings to: a) valid molecules b) methane molecules. c) drug-like molecules.
4.1.1 Implementation
The implementation details of the encoder-decoder network as well as the sparse GP for modelling
the objective remain unchanged from [Gómez-Bombarelli et al., 2018]. For the constrained Bayesian
optimization algorithm, the BNN is constructed with 2 hidden layers each 100 units wide with ReLU
activation functions and a logistic output. Minibatch size is set to 1000 and the network is trained for
5 epochs with a learning rate of 0.0005. 20 iterations of parallel Bayesian optimization are performed
using the Kriging-Believer algorithm in all cases. Data is collected in batch sizes of 50. The same
training set as [Gómez-Bombarelli et al., 2018] is used, namely 249, 456 drug-like molecules drawn
at random from the ZINC database [Irwin et al., 2012].
4.1.2 Diagnostic Experiments and Labelling Criteria
These experiments were designed to test the hypothesis that points collected by Bayesian optimization
lie far away from the training data in latent space. In doing so, they also serve as labelling criteria for
the data collected to train the BNN acting as the constraint function. The resulting observations are
summarized in Figure 3.
There is a noticeable decrease in the percentage of valid molecules decoded as one moves further
away from the training data in latent space. Points collected by Bayesian optimization do the worst in
terms of the percentage of valid decodings. This would suggest that these points lie farthest from
the training data. The decoder over-generates methane molecules when far away from the data. One
hypothesis for why this is the case is that methane is represented as ’C’ in the SMILES syntax and is
by far the most common character. Hence far away from the training data, combinations such as ’C’
followed by a stop character may have high probability under the distribution over sequences learned
by the decoder.
Given that methane has far too low a molecular weight to be a suitable drug candidate, a third plot,
3(c), shows the percentage of decoded molecules such that the molecules are both valid and have a
tangible molecular weight. The definition of a tangible molecular weight was interpreted somewhat
arbitrarily as a SMILES length of 5 or greater. Henceforth, molecules that are both valid and have
a SMILES length greater than 5 will be loosely referred to as drug-like. This is not to imply that a
molecule comprising five SMILES characters is likely to be drug-like, but rather this SMILES length
serves the purpose of determining whether the decoder has been successful or not.
As a result of these diagnostic experiments, it was decided that the criteria for labelling latent points
to initialize the binary classification neural network for the constraint would be the following: if the
latent point decodes into drug-like molecules in more than 20% of decode attempts, it should be
classified as drug-like and non drug-like otherwise.
4.1.3 Molecular Validity
The BNN for the constraint was initialized with 117, 440 positive class points and 117, 440 negative
class points. The positive points were obtained by running the training data through the decoder
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(a) Drug-like Molecules (b) New Drug-like Molecules
Figure 4: a) The percentage of latent points decoded to drug-like molecules. The results are from 20
iterations of Bayesian optimization with batches of 50 data points collected at each iteration (1000
latent points decoded in total). The standard error is given for 5 separate train/test set splits of 90/10.
(a) Composite LogP (b) Composite QED (c) QED
Figure 5: The best scores for new molecules generated from the baseline model (blue) and the model
with constrained Bayesian optimization (red). The vertical lines show the best scores averaged over 5
separate train/test splits of 90/10. For reference, the histograms are presented against the backdrop of
the top 10% of the training data in the case of Composite LogP and QED, and the top 20% of the
training data in the case of Composite QED.
assigning them positive labels if they satisfied the criteria outlined in the previous section. The
negative class points were collected by decoding points sampled uniformly at random across the
56 latent dimensions of the design space. Each latent point undergoes 100 decode attempts and
the most probable SMILES string is retained. J logPcomp(z) is the choice of objective function. The
relative performance of constrained Bayesian optimization and unconstrained Bayesian optimization
(baseline) [Gómez-Bombarelli et al., 2018] is compared in Figure 4.
The results show that greater than 80% of the latent points decoded by constrained Bayesian optimiza-
tion produce drug-like molecules compared to less than 5% for unconstrained Bayesian optimization.
One must account however, for the fact that the constrained approach may be decoding multiple
instances of the same novel molecules. Constrained and unconstrained Bayesian optimization are
compared on the metric of the percentage of unique novel molecules produced in 4(b).
One may observe that constrained Bayesian optimization outperforms unconstrained Bayesian
optimization in terms of the generation of unique molecules, but not by a large margin. A manual
inspection of the SMILES strings collected by the unconstrained optimization approach showed that
there were many strings with lengths marginally larger than the cutoff point, which is suggestive of
partially decoded molecules. As such, a fairer metric for comparison should be the quality of the new
molecules produced as judged by the scores from the black-box objective function. This is examined
next.
4.1.4 Molecular Quality
The results of Figure 5 indicate that constrained Bayesian optimization is able to generate higher
quality molecules relative to unconstrained Bayesian optimization across the three drug-likeness
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Table 1: Percentile of the averaged new molecule score relative to the training data. The results of 5
separate train/test set splits of 90/10 are provided.
OBJECTIVE BASELINE CONSTRAINED
LOGP COMPOSITE 36± 14 92± 4
QED COMPOSITE 14± 3 72± 10
QED 11± 2 79± 4
Figure 6: The best scores for novel molecules generated by the constrained Bayesian optimization
model optimizing for PCE. The results are averaged over 3 separate runs with train/test splits of
90/10.
metrics introduced in section 2.3. Over the 5 independent runs, the constrained optimization procedure
in every run produced new drug-like molecules ranked in the 100th percentile of the distribution over
training set scores for the J logPcomp(z) objective and over the 90th percentile for the remaining objectives.
Table 1 gives the percentile that the averaged score of the new molecules found by each process
occupies in the distribution over training set scores.
4.2 Experiment II: Material Design
In order to show that the constrained Bayesian optimization approach is extensible beyond the realm
of drug design, we trained the model on data from the Harvard Clean Energy Project [Hachmann
et al., 2011, 2014] to generate molecules optimized for power conversion efficiency (PCE).
4.2.1 Implementation
A neural network was trained to predict the PCE of 200, 000 molecules drawn at random from the
Harvard Clean Energy Project dataset using 512-bit Morgan circular fingerprints Rogers and Hahn
[2010] as input features with bond radius of 2 using RDKit Landrum [2016]. If unmentioned the
details of the implementation remain the same as experiment I.
4.2.2 PCE Scores
The results are given in Figure 6. The averaged score of the new molecules generated lies above the
90th percentile in the distribution over training set scores. Given that the objective function in this
instance was learned using a neural network, advances in predicting chemical properties from data
Duvenaud et al. [2015], Ramsundar et al. [2015] are liable to yield concomitant improvements in the
optimized molecules generated through this approach.
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5 Concluding Remarks
The reformulation of the search procedure in the Automatic Chemical Design model as a constrained
Bayesian optimization problem has led to concrete improvements on two fronts:
1. Validity - The number of valid molecules produced by the constrained optimization proce-
dure offers a marked improvement over the original model.
2. Quality - For five independent train/test splits, the scores of the best molecules generated by
the constrained optimization procedure consistently ranked above the 90th percentile of the
distribution over training set scores for all objectives considered.
These improvements provide strong evidence that constrained Bayesian optimization is a good
solution method for the training set mismatch pathology present in the unconstrained approach
for molecule generation. More generally, we foresee that constrained Bayesian optimization
is a workable solution to the training set mismatch problem in any VAE-based Bayesian opti-
mization scheme. Our code is made publicly available at https://github.com/Ryan-Rhys/
Constrained-Bayesian-Optimisation-for-Automatic-Chemical-Design. Further work
could feature improvements to the constraint scheme Rainforth et al. [2016], Mahmood and
Hernández-Lobato [2019], Astudillo and Frazier [2019], 201, Moriconi et al. [2019], Bartz-Beielstein
and Zaefferer [2017]. In terms of objectives for molecule generation, recent work by Blaschke et al.
[2017], Polykovskiy et al. [2018a], Tabor et al. [2018], Aumentado-Armstrong [2018], Sanchez-
Lengeling and Aspuru-Guzik [2018b] has featured a more targeted search for novel compounds. This
represents a move towards more industrially-relevant objective functions for Bayesian Optimization
which should ultimately replace the chemically mis-specified objectives, such as the penalized logP
score, identified both here and in Griffiths et al. [2018]. In addition, efforts at benchmarking gen-
erative models of molecules Brown et al. [2019], Polykovskiy et al. [2018b] should also serve to
advance the field.
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(a) Minima Locations (b) Disk Constraint
Figure 7: Constrained Bayesian optimization of the 2D Branin-Hoo Function.
A Toy Experiment: The Branin-Hoo Function
The Branin-Hoo function is a toy problem on which to test the functionality of the algorithmic
implementation for constrained Bayesian optimization. The particular variant of the Branin-
Hoo optimization of interest here is the constrained formulation of the problem as featured in
[Gelbart et al., 2014]. This Branin-Hoo function has three global minima at the coordinates
(−pi, 12.275), (pi, 2.275) and (9.42478, 2.475). In order to formulate the problem as a constrained
optimization problem, a disk constraint on the region of feasible solutions is introduced. In contrast to
the formulation of the problem in [Gelbart et al., 2014], the disk constraint is coupled in this scenario
in the sense that the objective and the constraint will be evaluated jointly at each iteration of Bayesian
optimization. In addition, the observations of the black-box objective function will be assumed to be
noise-free. The minima of the Branin-Hoo function as well as the disk constraint are illustrated in
Figure 7.
The disk constraint eliminates the upper-left and lower-right solutions, leaving a unique global
minimum at (pi, 2.275). Given that our implementation of constrained Bayesian optimization relies
on the use of a sparse GP as the underlying statistical model of the black-box objective and as such
is designed for scale as opposed to performance, the results will not be compared directly against
those of [Gelbart et al., 2014] who use an exact GP to model the objective. It will be sufficient to
compare the performance of the algorithm against random sampling. Both the sequential Bayesian
optimization algorithm and the parallel implementation using the Kriging-Believer algorithm are
tested.
A.1 Implementation
A Sparse GP featuring the FITC approximation, based on the implementation of [Bui et al., 2016] is
used to model the black-box objective function. The kernel choice is exponentiated quadratic with
automatic relevance determination (ARD). The number of inducing points M was chosen to be 20
in the case of sequential Bayesian optimization, and 5 in the case of parallel Bayesian optimization
using the Kriging-Believer algorithm. The sparse GP is trained for 400 epochs using Adam [Kingma
and Ba, 2014] with the default parameters and a learning rate of 0.005. The minibatch size is chosen
to be 5. The extent of jitter is chosen to be 0.00001. A Bayesian Neural Network (BNN), adapted
from the MNIST digit classification network of [Hernández-Lobato et al., 2016] is trained using
black-box alpha divergence minimization to model the constraint.
The network has a single hidden layer with 50 hidden units, Gaussian activation functions and logistic
output units. The mean parameters of q, the approximation to the true posterior, are initialized
by sampling from a zero-mean Gaussian with variance 2din+dout according to the method of [Glorot
and Bengio, 2010], where din is the dimension of the previous layer in the network and dout is the
dimension of the next layer in the network. The value of α is taken to be 0.5, minibatch sizes are
taken to be 10 and 50 Monte Carlo samples are used to approximate the expectations with respect to
q in each minibatch. The BNN adapted from [Hernández-Lobato et al., 2016] was implemented in
the Theano library [Theano Development Team, 2016]. The LBFGs method [Liu and Nocedal, 1989]
was used to optimize the EIC acquisition function in all experiments.
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Figure 8: a) Data points collected over 40 iterations of sequential Bayesian optimization. b) Contour
plot of the predictive mean of the sparse GP used to model the objective function. Lighter colours
indicate lower values of the objective. c) The contour learned by the BNN giving the probability of
constraint satisfaction.
Figure 9: Performance of Parallel Bayesian Optimization with EIC against Random Sampling.
A.2 Results
The results of the sequential constrained Bayesian optimization algorithm with EIC are shown in
Figure 8. The algorithm was initialized with 50 labeled data points drawn uniformly at random from
the grid depicted. 40 iterations of Bayesian optimization were carried out.
The figures show that the algorithm is correctly managing to collect data in the vicinity of the single
feasible minimum. Figure 9 compares the performance of parallel Bayesian optimization using the
Kriging-Believer algorithm against the results of random sampling. Both algorithms were initialized
using 10 data points drawn uniformly at random from the grid on which the Branin-Hoo function is
defined and were run for 10 iterations of Bayesian optimization. At each iteration a batch of 5 data
points was collected for evaluation.
After 10 iterations, the minimum feasible value of the objective function was 0.42 for parallel
Bayesian optimization with EIC using the Kriging-Believer algorithm and 2.63 for random sampling.
The true minimum feasible value is 0.40.
A.3 Discussion
The Branin-Hoo experiment is designed to yield some visual intuition for the constrained Bayesian
Optimization implementation in two dimensions before moving to higher dimensional molecular
space. The results demonstrate that the implementation of constrained Bayesian optimization is
behaving as expected in so far as the constraint in the problem is recognized and the search procedure
outperforms random sampling.
It could be worth performing some investigation into how much worse the sparse GP performs relative
to the full GP in the constrained setting. Another aspect that could be explored is the impact of the
initialization. It has recently been argued that different algorithms will vary in their performance
depending on how much information about the design space there is available [Morar et al., 2017].
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